Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
EDX Medical Group PLC on Monday posted a ‘positive’ outlook for its financial year, despite reporting a widened interim loss.
EDX Medical is a Cambridge, England-based company that develops digital diagnostic products and services for the treatment of cancer, heart disease, and infectious diseases.
In the six months ended September 30, revenue rose to £20,076, compared to no revenue a year earlier.
Its pretax loss widened, however, to £1.3 million from £684,854. Administrative expenses climbed to £1.3 million from £665,395.
Looking ahead EDX said the outlook for the remainder of the financial year remains ‘positive.’ It said that it now entering a new phase for the firm.
‘During the reporting period, the group has continued to develop its strategy of creating innovative digital diagnostic healthcare products and services to address major diseases and enable better treatment and outcomes for patients, said Chair Jason Holt.
‘The imperative for the group post this half-yearly interim reporting period remains growing our business rapidly as opportunities emerge to take forward products and projects with significant commercial potential.’
Copyright 2023 Alliance News Ltd. All Rights Reserved.